{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:45:03Z","timestamp":1760233503605,"version":"build-2065373602"},"reference-count":18,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Data"],"abstract":"<jats:p>Quantitative and qualitative data on active-ingredient drug composition are essential information for characterizing near-field exposure of consumers to product-related chemicals, among other things. Equally as important is the characterization of the relationship between one or many active ingredients in terms of the diseases they are prescribed for. Such evaluations, however, require quantitative information at different anatomical levels. To complement the available sources of information on active substances and diseases, we have designed a database with enough versatility to potentially be used in a variety of analyzes. By using information provided by a well-established online pharmacological dictionary, we present a database with 11 tables which are easy to access and manipulate. Specifically, we present datasets containing the details of 12,827 marketed drug products, 40,164 diseases, 6231 active pharmaceutical ingredients and 4093 side effects. We exemplify the usefulness of our database with three simple visualizations, which confirm the importance of the data for quantifying the complexity in the associations among active substances, diseases and side effects. Although there are databases with detailed information on active substances and diseases, none of them can be found in Spanish. Our work presents an option that contributes substantially to obtaining well classified information in order to evaluate the roles of active pharmaceutical ingredients, diseases and side effects. These datasets also provide information about clinical and pharmacological groupings which may be useful for clinical and academic researchers. The database will be regularly updated and extended with the newly available Virtual Medicinal Products.<\/jats:p>","DOI":"10.3390\/data6010003","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T19:55:56Z","timestamp":1610308556000},"page":"3","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drugs, Active Ingredients and Diseases Database in Spanish. Augmenting the Resources for Analyses on Drug\u2013Illness Interactions"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0783-107X","authenticated-orcid":false,"given":"Irene","family":"L\u00f3pez-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Unidad Interdisciplinaria en Ingenier\u00eda y Tecnolog\u00edas Avanzadas, Instituto Polit\u00e9cnico Nacional, Av. IPN No. 2580, L. Ticom\u00e1n, Ciudad de M\u00e9xico 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-8810","authenticated-orcid":false,"given":"C\u00e9sar F.","family":"Reyes-Manzano","sequence":"additional","affiliation":[{"name":"Tecnol\u00f3gico Nacional de M\u00e9xico, Tecnol\u00f3gico de Estudios Superiores de Ixtapaluca, Km. 7 Carretera Ixtapaluca-Coatepec S\/N San Juan, Ixtapaluca, Estado de M\u00e9xico 56580, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7895-802X","authenticated-orcid":false,"given":"Israel","family":"Reyes-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Unidad Interdisciplinaria en Ingenier\u00eda y Tecnolog\u00edas Avanzadas, Instituto Polit\u00e9cnico Nacional, Av. IPN No. 2580, L. Ticom\u00e1n, Ciudad de M\u00e9xico 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-3774","authenticated-orcid":false,"given":"Tania J.","family":"Contreras-Uribe","sequence":"additional","affiliation":[{"name":"Tecnol\u00f3gico Nacional de M\u00e9xico, Tecnol\u00f3gico de Estudios Superiores de Ixtapaluca, Km. 7 Carretera Ixtapaluca-Coatepec S\/N San Juan, Ixtapaluca, Estado de M\u00e9xico 56580, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-8796","authenticated-orcid":false,"given":"Lev","family":"Guzm\u00e1n-Vargas","sequence":"additional","affiliation":[{"name":"Unidad Interdisciplinaria en Ingenier\u00eda y Tecnolog\u00edas Avanzadas, Instituto Polit\u00e9cnico Nacional, Av. IPN No. 2580, L. Ticom\u00e1n, Ciudad de M\u00e9xico 07340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/4243","article-title":"Diversification of the drug discovery process","volume":"16","author":"Krantz","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"Guney","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1073\/pnas.1603992113","article-title":"Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets","volume":"113","author":"Vinayagam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13238-012-2011-z","article-title":"Study of drug function based on similarity of pathway fingerprint","volume":"3","author":"Ye","year":"2012","journal-title":"Protein Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug Discovery: A Historical Perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.trci.2017.10.005","article-title":"Drug discovery and development: Role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_8","unstructured":"Leaders (2020, March 06). Getting Medicines to Market Faster. Available online: https:\/\/www.economist.com\/leaders\/2018\/03\/24\/getting-medicines-to-market-faster."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: Shedding new light on drug metabolism","volume":"42","author":"Law","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"D963","DOI":"10.1093\/nar\/gky963","article-title":"DrugCentral 2018: An update","volume":"47","author":"Ursu","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_12","unstructured":"Spain, V.V. (2019, November 30). Vidal Vademecum Spain, Su Fuente de Conocimiento Farmacol\u00f3gico. Available online: https:\/\/www.vademecum.es\/."},{"key":"ref_13","unstructured":"European Commission (2020, February 02). European Commission\u2014Centralised Medicinal Products for Human Use by ATC Code. Available online: http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/reg_hum_atc.htm."},{"key":"ref_14","unstructured":"World Health Organization (2020, February 02). World Health Organization, Anatomical Therapeutic Chemical Classification System. Available online: https:\/\/www.whocc.no\/."},{"key":"ref_15","unstructured":"World Health Organization (2020, February 02). World Health Organization, International Statistical Classification of Diseases and Related Health Problems. Available online: http:\/\/www.who.int\/classifications\/."},{"key":"ref_16","unstructured":"Winkler, W.E. (1990, January 6\u20139). String Comparator Metrics and Enhanced Decision Rules in the Fellegi-Sunter Model of Record Linkage. Proceedings of the Section on Survey Research Methods, Anaheim, CA, USA."},{"key":"ref_17","unstructured":"(2020, October 30). FigShare. Available online: https:\/\/figshare.com\/s\/5b3128788640d7aa7d4f."},{"key":"ref_18","unstructured":"Smith, D.G. (2020, September 30). The 3 Most Promising Coronavirus Treatments, Explained. Available online: https:\/\/elemental.medium.com\/the-3-most-promising-coronavirus-treatments-explained-752e2c6d54d7."}],"container-title":["Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5729\/6\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:09:16Z","timestamp":1760159356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5729\/6\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["data6010003"],"URL":"https:\/\/doi.org\/10.3390\/data6010003","relation":{},"ISSN":["2306-5729"],"issn-type":[{"type":"electronic","value":"2306-5729"}],"subject":[],"published":{"date-parts":[[2021,1,9]]}}}